Skip to main content
. 2022 Mar 11;43(19):1809–1828. doi: 10.1093/eurheartj/ehac102

Figure 3.

Figure 3

Progression of bone marrow activation. Prevalence of metabolic syndrome, central obesity, hypertension, dyslipidaemia, and leucocytosis stratified by quintiles of bone marrow 18F-fluorodeoxyglucose uptake.